Should I Buy CLB? CLB 2026 Analysis

Should You Buy Core Laboratories Inc (CLB) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

19.640

1 Day change

4.36%

52 Week Range

20.360

Analysis Updated At

2026/01/29

Core Laboratories Inc (CLB) is not a strong buy at the moment for a beginner investor with a long-term focus. While the company has shown positive financial growth in the latest quarter, the technical indicators and options data suggest a neutral to slightly bearish sentiment in the short term. Additionally, there are no significant positive catalysts or trading signals to justify an immediate buy decision.

Technical Analysis

The stock's technical indicators present mixed signals. The MACD is below 0 and negatively contracting, indicating weak momentum. RSI is neutral at 58.956, and the moving averages are bullish (SMA_5 > SMA_20 > SMA_200). Support and resistance levels suggest a potential range-bound movement, with key support at 18.69 and resistance at 20.56. Overall, the technical outlook is neutral.

Options Data

Bullish

Open Interest Put-Call Ratio

Bearish

Option Volume Put-Call Ratio

The open interest put-call ratio of 0.65 indicates more interest in calls than puts, but the option volume put-call ratio of 1.2 suggests higher trading activity in puts, reflecting a cautious sentiment. Implied volatility is high at 72.27, with an IV percentile of 81.2, indicating potential price swings.

Technical Summary

Sell

Buy

Positive Catalysts

The company's financial performance in Q3 2025 showed positive growth, with revenue up 0.09% YoY, net income up 21.23% YoY, EPS up 20% YoY, and gross margin up 8.71% YoY. Moving averages are bullish, which could support long-term price stability.

Neutral/Negative Catalysts

No significant news or events in the past week. Stock trend analysis suggests a 40% chance of negative price movement in the short term (-1.93% next day, -1.81% next week, -3.19% next month). Options data indicates cautious sentiment, and there are no recent trading signals or congress trading activity.

Financial Performance

In Q3 2025, Core Laboratories Inc reported revenue of $134.52M, up 0.09% YoY. Net income increased significantly by 21.23% YoY to $14.24M, and EPS rose by 20% YoY to 0.3. Gross margin improved to 19.35%, up 8.71% YoY. The financials reflect solid growth trends.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No recent updates on analyst ratings or price target changes were provided. Wall Street sentiment appears neutral with no significant pros or cons highlighted.

1 Analyst Rating

Wall Street analysts forecast CLB stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for CLB is 11.5 USD with a low forecast of 11.5 USD and a high forecast of 11.5 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

0 Buy

0 Hold

1 Sell

Moderate Sell

Current: 18.820

Low

11.5

Averages

11.5

High

11.5

Current: 18.820

Low

11.5

Averages

11.5

High

11.5

Stifel

Hold

downgrade

$13 -> $12

AI Analysis

2025-07-16

Reason

Stifel

Price Target

$13 -> $12

AI Analysis

2025-07-16

downgrade

Hold

Reason

Stifel lowered the firm's price target on Core Laboratories to $12 from $13 and keeps a Hold rating on the shares. Oil service stocks have underperformed the S&P 500 in 2025, and catalysts have been largely negative, the analyst tells investors in a research note. Entering Q2 earnings season, the firm believes shares will be range bound until estimates stop falling.

Citi

Neutral

downgrade

$16 -> $13

2025-05-13

Reason

Citi

Price Target

$16 -> $13

2025-05-13

downgrade

Neutral

Reason

Citi lowered the firm's price target on Core Laboratories to $13 from $16 and keeps a Neutral rating on the shares. The firm updated models for a collection of Smid-cap oil and gas equipment and services stocks to incorporate updated rig count forecasts and recent earnings.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for CLB

Unlock Now

CLB Should I Buy

CLB Should I Buy

Should You Buy Core Laboratories Inc (CLB) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch